Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookUganda Pharmaceutical Sector Baseline Survey (HAI, WHO; 2002; 67 pages)
View the documentForeword
View the documentAcknowledgments
View the documentAbbreviations
View the documentExecutive summary
Open this folder and view contents1. Introduction
close this folder2. Study Design and Methodology
View the document2.1 Objectives of the survey
close this folder2.2 Methodology
View the documenta) Level I indicators
View the documentb) List of Level II indicators
View the documentc) List of household survey indicators
View the documentd) Training and Sampling
View the documente) The survey
View the documentf) Ethical Considerations
Open this folder and view contents3. Findings
View the document4. Interpretation of Results
Open this folder and view contents5. Conclusions and Recommendations
Open this folder and view contentsANNEXES
 

f) Ethical Considerations

The study was not expected to raise any significant ethical issues because the methods of study are regularly employed in similar studies in Uganda. The issues studied fall within the regular activities and mandate of the Ministry of Health (MOH), which commissioned the study. However, permission was sought and obtained from district authorities and private drug outlets before the actual survey could be conducted.

Introductory letters by the Director General of Health Services MOH were given to data collectors to present for this purpose.

Confidentiality was ensured for all information collected and no reference is made to specific patients or study units.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French